Allergy tablets under the tongue may cut hay fever drug use for years, massive real-world study suggests

NCT ID NCT05476484

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study looks back at health records from over 46,000 people in Denmark and Sweden with allergic rhinitis (hay fever), some of whom also have asthma. It compares those who used SQ sublingual immunotherapy (SLIT) tablets — a daily tablet placed under the tongue containing grass pollen or house dust mite allergens — to similar people who did not. The goal is to see whether long-term use of these tablets reduces the need for symptom-relieving allergy and asthma medications and lowers the risk of asthma attacks or lung infections.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
SQ sublingual immunotherapy (SLIT) tablets containing grass pollen or house dust mite allergens
What this could lead to
If successful, this could confirm that allergy tablets are a practical, long-term option for controlling allergic rhinitis and reducing reliance on symptom-relieving drugs.
What could go wrong
Because this is a retrospective register study, it can show associations but not prove cause and effect. Results may be influenced by differences between people who chose treatment and those who did not.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALLERGIC RHINITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • ALK

    Hørsholm, Copenhagen, DK-2970, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.